Results 241 to 250 of about 5,807 (256)

T cell engagers in autoimmune diseases

Nature Reviews Immunology
Ricardo Grieshaber-Bouyer, Lei Wu, Georg Schett, Patrick A. Baeuerle   +3 more
openaire   +1 more source

Mechanistic PKPD modeling to describe cytokine release associated with CD3 T-cell engager therapies

Frontiers in Immunology
Zinnia P Parra-Guillén, Parra-Guillén Zinnia P   +1 more
exaly  

Pre-Clinical Assessment of SAR442257, a CD38/CD3xCD28 Trispecific T Cell Engager in Treatment of Relapsed/Refractory Multiple Myeloma

Cells
, Lukas John, Irène Sarkar
exaly  

BISPECIFIC T CELL ENGAGING ANTIBODY CONSTRUCTS

2017
RAUM TOBIAS, MÜNZ MARKUS, BROZY JOHANNES, KUFER PETER, HOFFMANN PATRICK, FRIEDRICH MATTHIAS, RATTEL BENNO, BOGNER PAMELA, WOLF ANDREAS, POMPE CORNELIUS   +9 more
openaire   +4 more sources

Using protein geometry to optimize cytotoxicity and the cytokine window of a ROR1 specific T cell engager

Frontiers in Immunology
Harald Kolmar, Kolmar Harald
exaly  

Characterization of Bispecific T-cell Engager (BiTE®) Antibodies with a High-Capacity T-cell Dependent Cellular Cytotoxicity (TDCC) Assay

SLAS Discovery, 2015
exaly  

VECTORIZATION OF MUC1 T CELL ENGAGER

2022
MARCHAND JEAN-BAPTISTE, REMY CHRISTELLE
openaire   +1 more source

FORMULATION FOR BISPECIFIC T-CELL ENGAGERS (BITES)

2014
OLBRICH CARSTEN, BUNTE THOMAS, WINTER JONAS, PETERS JÖRG, TRILL THOMAS   +4 more
openaire   +3 more sources

Tumor flare with T-cell-engaging bispecific antibodies

Leukemia & Lymphoma
Carmelo Carlo-Stella, Michael J. Dickinson, Gloria Iacoboni, Cecilia Carpio, Natalie Dimier, Martin Weisser, Antonia Kwan, Cristiano Ferlini   +7 more
openaire   +2 more sources

DR30318, a novel tri-specific T cell engager for Claudin 18.2 positive cancers immunotherapy

Cancer Immunology, Immunotherapy
Chaonan Ye, Yu Lushan
exaly